WO2004046140A1 - Isothiazolyl-benzoxazine derivatives - Google Patents

Isothiazolyl-benzoxazine derivatives Download PDF

Info

Publication number
WO2004046140A1
WO2004046140A1 PCT/EP2003/012475 EP0312475W WO2004046140A1 WO 2004046140 A1 WO2004046140 A1 WO 2004046140A1 EP 0312475 W EP0312475 W EP 0312475W WO 2004046140 A1 WO2004046140 A1 WO 2004046140A1
Authority
WO
WIPO (PCT)
Prior art keywords
carbon atoms
isothiazolyl
formula
alkyl
alkoxy
Prior art date
Application number
PCT/EP2003/012475
Other languages
French (fr)
Inventor
Lutz Assmann
Yoshinori Kitagawa
Takuma Shigyo
Michael OELGEMÖLLER
Haruko Sawada
Original Assignee
Bayer Cropscience Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Aktiengesellschaft filed Critical Bayer Cropscience Aktiengesellschaft
Priority to AU2003288012A priority Critical patent/AU2003288012A1/en
Publication of WO2004046140A1 publication Critical patent/WO2004046140A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/86Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms six-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • the present invention relates to novel isothiazolyl-benzoxazine derivatives, to a process for their preparation and to their use as microbicides. Further, the invention relates to novel intermediates and to a process for their preparation.
  • R represents halogen, alkyl, alkoxy, alkylthio, alkylsulfonyl, haloalkyl, halo- alkoxy, carboxy, N,N-dialkyl-sulfamoyl, acylamino, alkoxycarbonylamino, phenyl, phenoxy or nitro, or two adjacent radicals may together form a group selected from alkylene, alkenylene, alkylenedioxy or haloalkylenedioxy, and
  • n . 0, 1, 2, 3 or 4.
  • n an integer of 2 or more, the radicals may be identical or different.
  • R and n have the above-mentioned meanings
  • isothiazolyl-benzoxazine derivatives of the formula (I) are outstandingly active as microbicides in agriculture and horticulture, particularly as fungicides for the direct control of plant diseases or for causing resistance in plants against plant pathogens.
  • the isothiazolyl-benzoxazine derivatives according to the invention have a much better microbicidal activity than the already known compounds, which are structurally most similar and have the same type of action.
  • the terms quoted below have the following meanings:
  • Halogen and halogen in “haloalkyl”, “haloalkoxy” and “haloalkylenedioxy” represents fluoro, chloro, bromo or iodo. 5
  • Alkyl can be a straight-chain or a branched-chain and there can be exemplarily . mentioned, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, n-pentyl, n- hexyl, etc.
  • Alkylene can be a straight-chain or a branched-chain and includes, for example, trimethylene, methyltrimethylene, 2-memyltrimethylene, tetramethylene, etc.
  • Alkenylene can be a straight-chain or a branched-chain comprising two or more double bonds and includes, for example, butadienylene, 1-methylbutadienylene, 2- 15 methylbutadienylene, 1-ethylbutadienylene, 2-ethylbutadienylene, etc.
  • Alkoxy can be a straight-chain or a branched-chain and there can be exemplarily mentioned, methoxy, ethoxy, n- or iso-propoxy, n-, iso-, sec- or tert-butoxy, n- pentyloxy, n-hexyloxy, etc. 20
  • Alkylthio can be a straight-chain or a branched-chain and there can be exemplarily mentioned, methylthio, ethylthio, n- or iso-propylthio, n-, iso-, sec- or tert-butylthio, n-pentylthio, n-hexylthio, etc.
  • Alkylsulfonyl is an alkyl-SO 2 -group, the alkyl part of which can be a straight-chain or a branched-chain, and there can be exemplarily mentioned, methylsulfonyl, ethylsulfonyl, n- or iso-propylsulfonyl, n-, iso-, sec- or tert-butylsulfonyl, n- pentylsulfonyl, n-hexylsulfonyl, etc.
  • Haloalkyl represents straight-chain or branched-chain alkyl, wherein at least one of the hydrogen atoms is substituted by halogen, and there can be exemplarily mentioned, C alkyl substituted with 1-9 fluoro and/or chloro, and as specific examples there can be mentioned difluoromethyl, trifluoromethyl, chlorodifluoro- methyl, 2-fluoroethyl, 2-chloroethyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, 1,1,2,2,2-pentafluoroethyl, 2-chloro-l,l,2-trifluoroethyl, 3-fluoropropyl, 3-chloro- propyl, 2,2,3 ,3,3-pentafluoropropyl, 1,2,2,3,3,3-hexafluoropropyl, perfluorobutyl, etc.
  • Haloalkoxy is a radical the haloalkyl part of which has the above-mentioned meanings, and there can be specifically mentioned, difluoromethoxy, chlorodifluoro- methoxy, trifluoromethoxy, 2-fiuoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2,2,2- trifluoroethoxy, 3-chloropropoxy, etc.
  • haloalkylenedioxy there can be exemplarily mentioned, difiuoromethylene- dioxy, tetrafluoroethylenedioxy, etc.
  • NjN-Dialkylsulfarnoyi is a radical the alkyl parts of which have the aforementioned meanings and there can be exemplarily mentioned, N,N-dimethyl- sulfamoyl, N,N-diethylsulfamoyl, N,N-di-(n-propyl)sulfamoyl, N,N-di(n-butyl)- sulfamoyl, etc.
  • Acylamino represents an alkyl-CO-NH-group, the alkyl part of which can be a straight-chain or a branched-chain, and there can be specifically mentioned acetylamino, propionylamino, butyrylamino, isobutyrylamino, valerylamino, isovalerylamino, pivaloylamino, etc.
  • Alkoxycarbonylamino is an alkoxy-CO- H-group, wherein the alkoxy part has the above-mentioned meanings and there can be exemplarily mentioned, methoxy- carbonylamino, ethoxycarbonylamino, n- or iso-propoxycarbonylamino, n-, iso-, sec- or tert-butoxycarbonylamino, etc.
  • Formula (I) provides a general definition of the isothiazolyl-benzoxazine derivatives according to the invention. Preferred compounds of the formula (I) are those in which
  • R represents fluoro, chloro, bromo, iodo, alkyl having 1 or 6 carbon atoms, alkoxy having 1 to 6 carbon atoms, alkylthio having 1 to 6 carbon atoms, alkylsulfonyl having 1 to 6 carbon atoms, haloalkyl having 1 to 6 carbon atoms and 1 to 9 identical or different halogen atoms, haloalkoxy having 1 to 6 carbon atoms and 1 to 9 identical or different halogen atoms, carboxy, N,N- dialkyl-sulfamoyl having 1 to 6 carbon atoms in each of the alkyl groups, alkylcarbonylamino having 1 to 6 carbon atoms in the alkyl part, alkoxy- carbonyla ino having 1 to 6 carbon atoms in the alkoxy part, phenyl, phenoxy or nitro,
  • n 0, 1, 2, 3, or 4.
  • n an integer of 2 or more, the radicals may be identical or different.
  • R represents fluoro, chloro, bromo, iodo, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, alkylthio having 1 to 4 carbon atoms, alkylsulfonyl having 1 to 4 carbon atoms, haloalkyl having 1 to 4 carbon atoms and 1 to 5 identical or different halogen atoms, haloalkoxy having 1 to 4 carbon atoms and 1 to 5 identical or different halogen atoms, carboxy, N,N- dialkyl-sulfamoyl having 1 to 4 carbon atoms in each of the alkyl groups, alkylcarbonylamino having 1 to 4 carbon atoms in the alkyl part, alkoxycarbonylamino having 1 to 4 carbon atoms in the alkoxy part, phenyl, phenoxy or nitro,
  • n 0, 1, 2, 3 or 4.
  • n represents an interger of 2 or more, the radicals may be identical or different.
  • R represents fluoro, chloro, bromo, iodo, methyl, ethyl, methoxy, ethoxy, methylthio, methylsulfonyl, trifluoromethyl, trichloromethyl, difluoromethyl, trifluoromethoxy, difluoromethoxy, carboxy, N,N-dimethyl-sulfamoyl, methylcarbonylamino, e&ylcarbonylarnino, methoxycarbonylamino, ethoxy- carbonylamino, phenyl, phenoxy or nitro, or
  • n 0, 1, 2, 3 or 4.
  • n an integer of 2 or more, the radicals may be identical or different.
  • An even more preferred group of compounds are those isothiazolyl-benzoxazine derivatives of the formula (I), wherein
  • R . represents fluoro, chloro, bromo, iodo, methyl, trifluoromethyl or nitro, or
  • n 0, 1 or 2, wherein the radicals may be identical or different, if n is 2.
  • Formula (II) provides a general definition of the isothiazolyl-carboxamides, which are required as starting materials for carrying out process (a) according to the invention.
  • R and n preferably have those meanings, which have already been mentioned as preferred for this radical and this index.
  • the isothiazolyl-carboxamides of the formula (JJ) are novel. They can be prepared by
  • R and n have the above-mentioned meanings
  • the 3,4-dichlor ⁇ -isothiazole-5-carboxylic acid chloride of the formula (III) is a known compound (cf. JP-A 59024-1993).
  • Formula (IV) provides a general definition of the benzoic acid derivatives, which are required as reaction components for carrying out process (b) according to the invention.
  • R and n preferably have those meanings, which have already been mentioned in connection with the description of the substances of the formula (I) according to the invention as being preferred for this radical and this index.
  • the benzoic acid derivatives of the formula (IV) are known or can be prepared by known processes.
  • Suitable diluents for carrying out process (b) according to the invention are all customary inert organic solvents as well as water. Preference is given to using water.
  • Suitable acid binding agents for carrying out process (b) according to the invention are all bases, which are customary for such reactions. Preference is given to using hydroxides of alkali metals, such as hthium hydroxide, sodium hydroxide and potassium hydroxide.
  • reaction temperatures can be varied within a certain range.
  • the reaction is generally carried out at a temperature between about 0°C and about 80°C, preferably between about 10°C and about 60°C.
  • 3,4-dichloro-isothiazole-5- carboxylic acid chloride of the formula (UI) and benzoic acid derivative of the formula (TV) are generally employed in equimolar amounts. However, it is also possible to use an excess of one or the other component. Working up is carried out by customary methods.
  • the isothiazolyl-carboxamides of the formula (IT) are also suitable for the control of undesired microorganisms, in particular for controlling fungi.
  • all customary dehydrating agents can be used for splitting off water in the course of the reaction.
  • dehydrating agents are acetic anhydride, benzoic anhydride and propionic anhydride.
  • Suitable diluents for carrying out the process (a) according to the invention are all customary inert organic solvents. Preference is given to using aliphatic, alicyclic and aromatic hydrocarbons (that may optionally be chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloro- methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, di- chlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; ketones, for example, acetone, methyl e
  • reaction temperatures can be varied within a substantially wide range.
  • the reaction is generally carried out at temperatures between about -10°C and about 250°C, preferably between about 20°C and about 180°C.
  • the process (a) according to the invention is generally carried out under atmospheric pressure but, if desired, can also be carried out under elevated or reduced pressure.
  • an isothiazolyl-carboxamide of the formula (If) is reacted in the presence of a large excess of a dehydrating agent. If acetic anhydride is used as dehydrating agent it may simultaneously serve as a diluent. Working-up is carried out by customary methods.
  • the compounds according to the present invention exhibit a strong microbicidal activity. Thus, they can be used for combating undesired microorganisms, such as phytopathogenic fungi and bacteriae, in agriculture and horticulture.
  • the compounds are suitable for the direct control of undesired microorganisms as well as for generating resistance in plants against attack by undesired plant pathogens.
  • Resistance-inducing substances in the present context are to be understood as those substances which are capable of stimulating the defence system of plants such that the treated plants, when subsequently inoculated with undesirable microorganisms, display substantial resistance to these microorganisms.
  • Undesirable microorganisms in the present case are to be understood as phytopathogenic fungi and bacteriae.
  • the substances according to the invention can thus be employed to generate resistance in plants against attack by the harmful organisms mentioned within a certain period of time after the treatment.
  • the period of time within which resistance is brought about in general extends from 1 to 10 days, prefer- ably 1 to 7 days, after treatment of the plants with the active compounds.
  • the compounds according to the invention can be used as fungicides for combating phytopathogenic fungi, such as Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deutero- mycetes, and can also be used as bactericides for combating bacteriae, such as
  • Erwinia species such as, for example, Erwinia amylovora;
  • Pythium species such as, for example, Pythium ultimum
  • Phytophthora species such as, for example, Phytophthora infestans
  • Pseudoperonospora species such as, for example, Pseudoperonospora humuli or
  • Plasmopara species such as, for example, Plasmopara viticola
  • Bremia species such as, for example, Bremia Lactucae
  • Peronospora species such as, for example, Peronospora pisi or P. brassicae
  • Erysiphe species such as, for example, Erysiphe graminis
  • Sphaerotheca species such as, for example, Sphaerotheca fuliginea
  • Podosphaera species such as, for example, Podosphaera leucotricha
  • Venturia species such as, for example, Venturi inaequalis
  • Pyrenophora species such as, for example, Pyrenophora teres or P. graminea (conidia form: Drechslera, syn: Helminthosporium);
  • Cochliobolus species such as, for example, Cochliobolus sativus
  • Drechslera,syn Helminthosporium
  • Uromyces species such as, for example, Uromyces appendiculatus
  • Puccinia species such as, for example, Puccinia recondita
  • Sclerotinia species such as, for example, Sclerotinia sclerotiorum
  • Tilletia species such as, for example, Tilletia caries
  • Ustilago species such as, for example, Ustilago nuda or Ustilago avenae
  • Pellicularia species such as, for example, Pellicularia sasakii
  • Pyricularia species such as, for example, Pyricularia oryzae
  • Fusarium species such as, for example, Fusarium culmbrum
  • Botrytis species such as, for example, Botrytis cinerea
  • Septoria species such as, for example, Leptosphaeria nodorum
  • Cercospora species such as, for example, Cercospora canescens
  • Alternaria species such as, for example, Alternaria brassicae
  • Pseudocercosporella species such as, for example, Pseudocercosporella herpo- trichoides.
  • the compounds according to the present invention are particularly suitable for causing resistance against infection of plants by plant pathogens, such as Pyricularia oryzae etc.
  • the good toleration, by plants, of the active compounds, at the concentrations required for combating plants diseases permits treatment of above-ground parts of plants, of vegetative propagation stock and seeds, and of the soil.
  • the compounds according to the present invention have a low toxicity against warmblooded animals and therefore can be used safely.
  • the active compounds can be converted into the customary formulations, such as solutions, emulsions, wettable powders, suspensions, powders, foams, pastes, granu- les, tablets, aerosols, natural and synthetic materials impregnated with active compound, very fine capsules in polymeric substances, coating compositions for use on seed, and formulations used . with burning equipment, such as fumigating cartridges, fumigating cans and fumigating coils, as well as ULV cold mist and warm mist formulations.
  • customary formulations such as solutions, emulsions, wettable powders, suspensions, powders, foams, pastes, granu- les, tablets, aerosols, natural and synthetic materials impregnated with active compound, very fine capsules in polymeric substances, coating compositions for use on seed, and formulations used .
  • burning equipment such as fumigating cartridges, fumigating cans and fumigating coils, as well as ULV cold mist and warm mist formulations.
  • formulations may be produced in known manner, for example by mixing the active compounds with extenders, that is to say liquid or liquefied gaseous or solid diluents or carriers, optionally with the use of surface-active agents, that is to say emulsifying agents and/or dispersing agents and or foam-forming agents.
  • extenders that is to say liquid or liquefied gaseous or solid diluents or carriers
  • surface-active agents that is to say emulsifying agents and/or dispersing agents and or foam-forming agents.
  • organic solvents can, for example, also be used as auxiliary solvents.
  • liquid solvents diluents or carriers there are suitable in the main, aromatic hydrocarbons such as xylene, toluene or alkyl naphthalenes, chlorinated aromatic or chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example mineral oil fractions, alcohols, such as butanol or glycol as well as their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl-isobutyl ketone or cyclohexanone, or strongly polar solvents, such as dimethylformamide and dimethyl-sulphoxide, as well as water.
  • aromatic hydrocarbons such as xylene, toluene or alkyl naphthalenes
  • chlorinated aromatic or chlorinated aliphatic hydrocarbons such as chlorobenzene
  • liquefied gaseous diluents or carriers liquids which would be gaseous at normal temperature and under normal pressure, for example aerosol propellants, such as halogenated hydrocarbons as well as butane, propane, nitrogen and carbon dioxide.
  • ground natural minerals such as kaolings, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth,. and ground synthetic minerals, such as highly-dispersed silicic acid, alumina and silicates.
  • ground synthetic minerals such as highly-dispersed silicic acid, alumina and silicates.
  • crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, as well as synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks.
  • non-ionic and anionic emulsifiers such as polyoxyethylene-fatty acid esters, polyoxyethylene-fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkyl sulphonates, alkyl sulphates, aryl sulphonates as well as albumin hydrolysis products.
  • Dispersing agents include, for example, lignin sulphite waste liquors and methyl- cellulose.
  • Adhesives such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and poly- vinyl acetate, can be used in the formulation.
  • colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs or metal phthalocyanine dyestuffs, and trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • organic dyestuffs such as alizarin dyestuffs, azo dyestuffs or metal phthalocyanine dyestuffs
  • trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • the formulations in general contain from 0.1 to 95 per cent by weight of active compound, preferably from 0.5 to 90 per cent by weight.
  • the active compounds according to the invention can be present in the formulations or in the various use forms as a mixture with other known active compounds, such as fungicides, bactericides, insecticides, acaricides, nematicides, herbicides, bird repellents, growth factors, plant nutrients and agents for improving soil structure.
  • active compounds such as fungicides, bactericides, insecticides, acaricides, nematicides, herbicides, bird repellents, growth factors, plant nutrients and agents for improving soil structure.
  • Fungicides examples include the following compounds: Fungicides:
  • aldimorph ampropylfos, ampropylfos potassium, andoprim, anilazine, azaconazole, azoxystrobin, benalaxyl, benodanil, benomyl, benzamacril, benzamacril-isobutyl, bialaphos, binapacryl, biphenyl, bitertanol, blasticidin-S, bromuconazole, bupirimate, buthiobate, calcium polysulphide, capsimycin, captafol, captan, carbendazim, carboxin, carvon, quinomethionate, chlobenthiazone, chlorfenazole, chloroneb, chloropicrin, chloro- thalonil, chlozolinate, clozylacon, cufraneb, cymoxanil, cyproconazole, cyprodinil, cyprofuram, carprop
  • Bacillus thuringiensis strain EG-2348 Bacillus thuringiensis strain EG-2348,
  • the active compounds can be used as such or in the form of their formulations or the use forms prepared therefrom by further dilution, such as ready-to-use solutions, emulsions, suspensions, powders, tablets, pastes, microcapsules and granules. They are used in the customary manner, for example by watering, immersion, spraying, atomising, misting, vaporizing, injecting, forming a slurry, brushing on, dusting, scattering, dry dressing, moist dressing, wet dressing, slurry dressing or encrusting.
  • the active compounds concentration in the use forms can be varied within a substantial range. They are, in general, from 1 to
  • 0.0001% by weight preferably from 0.5 and 0.001%.
  • plants and parts of plants can be treated according to the invention.
  • naturally occurring plant species and plant varieties or those obtained by conventional biological breeding methods such as crossbreeding or protoplast fusion as well as parts of such plants are treated.
  • transgenic plants and plant varieties which have been obtained by genetic engineering methods possibly in combination with conventional methods (genetically modified organisms) and parts of such plants are treated.
  • the term "parts" or “parts of plants” or “plant parts” is explained above.
  • plants of the plant varieties commercially available or used at any particular time are very preferably treated.
  • Plant varieties are understood to be plants with specific properties ("traits") which have been obtained both by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can be varieties, biotypes or genotypes.
  • superadditive effects can occur as a result of the treatment according to the invention. Effects such as for example reduced application rates and/or broadening of the activity spectra and/or increased activity of the compounds and compositions usable according to the invention, improved plant growth, increased tolerance of high or low temperatures, increased tolerance of dry conditions or water or ground salt contents, increased flowering capacity, facilitated harvesting, acceleration of maturity, increased crop yields, higher quality and/or increased nutritional value of the harvested crops and increased storing quality and/or processibility of the harvested crops are possible, which are greater than those actually expected.
  • Preferred transgenic plants or plant varieties (obtained by genetic engineering) to be treated according to the invention include all plants which as a result of the genetic modification concerned have received genetic material which provides them with particularly advantageous valuable properties ("traits").
  • traits are improved plant growth, increased tolerance of high or low temperatures, increased tolerance of dry conditions or water or ground salt contents, increased flowering capacity, facilitated harvesting, acceleration of maturity, increased crop yields, higher quality and/or increased nutritional value of the harvested crops and increased storing quality and/or processibility of the harvested crops.
  • Additional and particularly noteworthy examples of such properties are increased resistance of the plants to animal and microbial pests, such as to insects, mites, phytopathogenic fungi, bacteria and/or viruses as well as increased tolerance by the plants of certain herbicidal active compounds.
  • transgenic plants examples which may be mentioned of transgenic plants are the important crop plants such as cereals (wheat and rice), corn, soybeans, potatoes, cotton, rape and fruit plants (producing apples, pears, citrus fruits and grapes), the crop plants com, soybeans, potatoes, cotton and rape being particularly noteworthy.
  • Particularly significant properties are increased resistance of the plants to insects due to the toxins forming in the plants, and in particular those which are produced in the plants (hereinafter referred to as "Bt plants”) by the genetic material obtained from Bacillus Thuringiensis (e.g.
  • traits are the increased resistance of plants to fungi, bacteria and viruses due to systemically acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and correspondingly expressed proteins and toxins.
  • SAR systemically acquired resistance
  • traits are also increased tolerance by the plants of certain herbicidal active compounds, such as for example imidazolinones, sulphonylureas, glyphosate or phosphinotricine (e.g. the "PAT" gene).
  • twins can also occur in the transgenic plants in combination with each other.
  • “Bt plants” are varieties of corn, cotton, soybeans and potatoes which are sold under the trade names YIELD GARD® (e.g. corn, cotton, soybeans), KnockOut® (e.g. corn), StarLink® (e.g. com), Bollgard® (cotton), Nucotn® (cotton) and NewLeaf® (potatoes).
  • herbicide-tolerant plants are varieties of corn, cotton and soybeans which are sold under the trade names Roundup Ready® (tolerance of glyphosate, e.g.
  • Herbicide- resistant plants (bred for herbicide tolerance in the conventional manner) which may be mentioned are also the varieties (e.g. com) sold under the name Clearfield®.
  • the above statements do of course also apply to any plant varieties which may be developed in the future or launched onto the market in the future and which have the genetic properties ("traits") described above or developed in the future.
  • the above-mentioned plants can be particularly advantageously treated with the compounds of the general formula I or the active compound mixtures according to the invention.
  • the preferred ranges mentioned above for the active compounds or mixtures also apply to the treatment of these plants.
  • Particularly advantageous is the treatment of plants with the compounds or mixtures specifically listed in the present text.
  • Active compound 30 - 40 parts by weight
  • Carrier mixture of diatomaceous earth and kaolin (1 :5), 55-65 parts by weight
  • Emulsifier polyoxyethylene alkyl phenyl ether, 5 parts by weight
  • Control value (%) x 100 Infection rate of untreated section
  • Seeds of paddy rice (variety: Kasabue) were drenched in a previously prepared diluted solution of an active compound having the prescribed concentration. 5 ml of such solution were used per 150 grains of seed. Drenching was conducted at a temperature of 20°C for 5 days. After the drenching, the air-dried seeds were sown in 2 plastic pots, each having a diameter of 9 cm, and the seeds were germinated by placing the pots in a warmed nursery box (32°C) for 3 days. After cultivating the seedlings for 2 weeks, the plants reached the 2 - 2.5 leaf stage.
  • a spore suspension of artificially cultured Pyricularia oryzae was then sprayed on the test plants once, and the plants were kept at a temperature of 25°C and a relative atmospheric humidity of 100% for infection. Seven days after the inoculation, the infection rate per pot was classified and evaluated and the control value (%) was calculated. Phytotoxicity was tested at the same time.
  • This test is an average of the results of 3 pots per one section.
  • An emulsifiable concentrate was prepared by mixing 30 parts by weight of Compound No. 1-6 according to the invention, 5 parts by weight of xylene, 8 parts by weight of polyoxyethylene alkyl phenyl ether and 7 parts by weight of calcium alkylbenzene sulphonate with stirring.
  • a wettable powder was prepared by thoroughly mixing 15 parts by weight of Com- pound No. 1-8 according to the invention, 80 parts by weight of a mixture (1:5) of
  • White Carbon fine powder of hydrated non-crystalline silicon oxide
  • powdery clay 2 parts by weight of sodium alkylbenzene sulphonate and 3 parts by weight of a condensate of sodium alkylnaphthalene sulphonate and formaldehyde in powdery state.
  • the resulting product was granulated by means of extrusion through a 0.3 mm screen. After drying the product, water dispersible granules were obtained.

Abstract

Novel isothiazolyl-benzoxazine derivatives of the formula (I) wherein R and n have the meanings given in the specification, a process for the preparation of the new compounds and their use as microbicides Novel intermediates of the formula (II) wherein R and n have the meanings given in the specification, and a process for the preparation of these intermediates.

Description

Isothiazolyl-benzoxazine Derivatives
The present invention relates to novel isothiazolyl-benzoxazine derivatives, to a process for their preparation and to their use as microbicides. Further, the invention relates to novel intermediates and to a process for their preparation.
It has already been known that certain benzoxazines can be employed for the control of plant pests (cf. JP-A 43 488-1999 and JP-A 19 691-2001). The activity of such known compounds, however, is not always satisfactory.
Further, it has already been disclosed that another group of benzoxazines is herbicidally active (cf. US-A 3 914.121, JP-A 141 476-1980 and 108 776-1981). The use of such compounds as microbicides, however, has not been described as yet.
After all, it has already been known that a group of thiadiazole derivatives comprising a benzoxazine.ring as a part of the molecule can be employed for the control of harmful organisms (cf. JP-A 139 566-2001). At low dosages, however, the activity of these compounds is not always satisfactory.
There have now been found novel isothiazolyl-benzoxazine derivatives of the formula
Figure imgf000003_0001
wherein
R represents halogen, alkyl, alkoxy, alkylthio, alkylsulfonyl, haloalkyl, halo- alkoxy, carboxy, N,N-dialkyl-sulfamoyl, acylamino, alkoxycarbonylamino, phenyl, phenoxy or nitro, or two adjacent radicals may together form a group selected from alkylene, alkenylene, alkylenedioxy or haloalkylenedioxy, and
n . represents 0, 1, 2, 3 or 4.
If n represents an integer of 2 or more, the radicals may be identical or different.
Further, it has been found that the isothiazolyl-benzoxazine derivatives of the formula (I) can be prepared by a process, in which
a) isothiazolyl-caboxamides of the formula
Figure imgf000004_0001
wherein
R and n have the above-mentioned meanings,
are reacted with dehydrating agents in the presence of an inert diluent.
Finally, it has been found that the isothiazolyl-benzoxazine derivatives of the formula (I) are outstandingly active as microbicides in agriculture and horticulture, particularly as fungicides for the direct control of plant diseases or for causing resistance in plants against plant pathogens.
Surprisingly, the isothiazolyl-benzoxazine derivatives according to the invention have a much better microbicidal activity than the already known compounds, which are structurally most similar and have the same type of action. In the present context, the terms quoted below have the following meanings:
"Halogen" and halogen in "haloalkyl", "haloalkoxy" and "haloalkylenedioxy" represents fluoro, chloro, bromo or iodo. 5
"Alkyl" can be a straight-chain or a branched-chain and there can be exemplarily . mentioned, methyl, ethyl, n- or iso-propyl, n-, iso-, sec- or tert-butyl, n-pentyl, n- hexyl, etc.
■10 "Alkylene" can be a straight-chain or a branched-chain and includes, for example, trimethylene, methyltrimethylene, 2-memyltrimethylene, tetramethylene, etc.
"Alkenylene" can be a straight-chain or a branched-chain comprising two or more double bonds and includes, for example, butadienylene, 1-methylbutadienylene, 2- 15 methylbutadienylene, 1-ethylbutadienylene, 2-ethylbutadienylene, etc.
"Alkoxy" can be a straight-chain or a branched-chain and there can be exemplarily mentioned, methoxy, ethoxy, n- or iso-propoxy, n-, iso-, sec- or tert-butoxy, n- pentyloxy, n-hexyloxy, etc. 20
"Alkylthio" can be a straight-chain or a branched-chain and there can be exemplarily mentioned, methylthio, ethylthio, n- or iso-propylthio, n-, iso-, sec- or tert-butylthio, n-pentylthio, n-hexylthio, etc.
25 "Alkylsulfonyl" is an alkyl-SO2-group, the alkyl part of which can be a straight-chain or a branched-chain, and there can be exemplarily mentioned, methylsulfonyl, ethylsulfonyl, n- or iso-propylsulfonyl, n-, iso-, sec- or tert-butylsulfonyl, n- pentylsulfonyl, n-hexylsulfonyl, etc.
30 "Haloalkyl" represents straight-chain or branched-chain alkyl, wherein at least one of the hydrogen atoms is substituted by halogen, and there can be exemplarily mentioned, C alkyl substituted with 1-9 fluoro and/or chloro, and as specific examples there can be mentioned difluoromethyl, trifluoromethyl, chlorodifluoro- methyl, 2-fluoroethyl, 2-chloroethyl, 2,2,2-trifluoroethyl, 1,1,2,2-tetrafluoroethyl, 1,1,2,2,2-pentafluoroethyl, 2-chloro-l,l,2-trifluoroethyl, 3-fluoropropyl, 3-chloro- propyl, 2,2,3 ,3,3-pentafluoropropyl, 1,2,2,3,3,3-hexafluoropropyl, perfluorobutyl, etc.
"Haloalkoxy" is a radical the haloalkyl part of which has the above-mentioned meanings, and there can be specifically mentioned, difluoromethoxy, chlorodifluoro- methoxy, trifluoromethoxy, 2-fiuoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2,2,2- trifluoroethoxy, 3-chloropropoxy, etc.
As "haloalkylenedioxy" there can be exemplarily mentioned, difiuoromethylene- dioxy, tetrafluoroethylenedioxy, etc.
"NjN-Dialkylsulfarnoyi" is a radical the alkyl parts of which have the aforementioned meanings and there can be exemplarily mentioned, N,N-dimethyl- sulfamoyl, N,N-diethylsulfamoyl, N,N-di-(n-propyl)sulfamoyl, N,N-di(n-butyl)- sulfamoyl, etc.
"Acylamino" represents an alkyl-CO-NH-group, the alkyl part of which can be a straight-chain or a branched-chain, and there can be specifically mentioned acetylamino, propionylamino, butyrylamino, isobutyrylamino, valerylamino, isovalerylamino, pivaloylamino, etc.
"Alkoxycarbonylamino" is an alkoxy-CO- H-group, wherein the alkoxy part has the above-mentioned meanings and there can be exemplarily mentioned, methoxy- carbonylamino, ethoxycarbonylamino, n- or iso-propoxycarbonylamino, n-, iso-, sec- or tert-butoxycarbonylamino, etc. Formula (I) provides a general definition of the isothiazolyl-benzoxazine derivatives according to the invention. Preferred compounds of the formula (I) are those in which
R represents fluoro, chloro, bromo, iodo, alkyl having 1 or 6 carbon atoms, alkoxy having 1 to 6 carbon atoms, alkylthio having 1 to 6 carbon atoms, alkylsulfonyl having 1 to 6 carbon atoms, haloalkyl having 1 to 6 carbon atoms and 1 to 9 identical or different halogen atoms, haloalkoxy having 1 to 6 carbon atoms and 1 to 9 identical or different halogen atoms, carboxy, N,N- dialkyl-sulfamoyl having 1 to 6 carbon atoms in each of the alkyl groups, alkylcarbonylamino having 1 to 6 carbon atoms in the alkyl part, alkoxy- carbonyla ino having 1 to 6 carbon atoms in the alkoxy part, phenyl, phenoxy or nitro,
or two adjacent radicals together form a group selected from alkylene having
3 to 6 carbon atoms, alkenylene having 4 to 6 carbon atoms, alkylenedioxy having 1 or 2 carbon atoms and 2 non-adjacent oxygen atoms, or halo- alkylenedioxy having 1 to 4 carbon atoms and 2 non- adjacent oxygen atoms and 1 to 5 identical or different halogen atoms, and
n is 0, 1, 2, 3, or 4.
If n represents an integer of 2 or more, the radicals may be identical or different.
Particularly, preferred are isothiazolyl-benzoxazme derivatives of the formula (I), wherein
R represents fluoro, chloro, bromo, iodo, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, alkylthio having 1 to 4 carbon atoms, alkylsulfonyl having 1 to 4 carbon atoms, haloalkyl having 1 to 4 carbon atoms and 1 to 5 identical or different halogen atoms, haloalkoxy having 1 to 4 carbon atoms and 1 to 5 identical or different halogen atoms, carboxy, N,N- dialkyl-sulfamoyl having 1 to 4 carbon atoms in each of the alkyl groups, alkylcarbonylamino having 1 to 4 carbon atoms in the alkyl part, alkoxycarbonylamino having 1 to 4 carbon atoms in the alkoxy part, phenyl, phenoxy or nitro,
or two adjacent radicals together form a group selected from -(CH2)3-, .-(CH2)4-, -CH=CH-CH=CH-, -O-CH2-O-, -O-CH2-CH2-O-, -O-CF2-O- and -O-CF2-CF2-O-, and
n is 0, 1, 2, 3 or 4.
If n represents an interger of 2 or more, the radicals may be identical or different.
Very particularly preferred are isothiazolyl-benzoxazine derivatives of the formula
(I), wherein
R represents fluoro, chloro, bromo, iodo, methyl, ethyl, methoxy, ethoxy, methylthio, methylsulfonyl, trifluoromethyl, trichloromethyl, difluoromethyl, trifluoromethoxy, difluoromethoxy, carboxy, N,N-dimethyl-sulfamoyl, methylcarbonylamino, e&ylcarbonylarnino, methoxycarbonylamino, ethoxy- carbonylamino, phenyl, phenoxy or nitro, or
two adjacent radicals represent a group selected from -(CH )3-, -(CH2)4-, -CH-CH-CH=CH-, -O-CH2-O-, -O-CH2-CH2-O-, -O-CF2-O- and
-O-CF2-CF2-O-, and
n is 0, 1, 2, 3 or 4.
If n represents an integer of 2 or more, the radicals may be identical or different. An even more preferred group of compounds are those isothiazolyl-benzoxazine derivatives of the formula (I), wherein
R . represents fluoro, chloro, bromo, iodo, methyl, trifluoromethyl or nitro, or
two adjacent radicals represent the group -CH=CH-CH=CH-, and
n is 0, 1 or 2, wherein the radicals may be identical or different, if n is 2.
If 5-bromo-2-(3,4-dichloro-isothiazol-5-yl-carbonylamino)-benzoic acid is used as starting material and acetic anhydride is used as dehydrating agent, the process (a) according to the invention can be illustrated by the following reaction scheme:
Figure imgf000009_0001
Formula (II) provides a general definition of the isothiazolyl-carboxamides, which are required as starting materials for carrying out process (a) according to the invention. In this formula, R and n preferably have those meanings, which have already been mentioned as preferred for this radical and this index.
The following compounds may be mentioned as specific examples of the isothiazolyl-carboxamides of the formula (II):
2-{[(3,4-dichloro-5-isotru^zolyl)carbonyl]amino}benzoic acid,
2-{[(3,4-dichloro-5-isothiazolyl)carbonyl]amino}-5-methylbenzoic acid, 2-{[(3,4-dichloro-5-isothiazolyl)carbonyl]amino}-5-fluorobenzoic acid, 2-{ [(3,4-dichloro ■5-isotru^olyl)carbonyl]amino} ■ ■5-chlorobenzoic acid,
2-{ [(3,4-dichloro ■5 -isothiazolyl)carbonyl] amino } • ■5-bromobenzoic acid,
2-{ [(3,4-dichloro •5-isothiazolyl)carbonyl]amino} • ■4-methylbenzoic acid,
2-{ [(3,4-dichloro •5-isothiazolyl)carbonyl]amino}- ■4-fluorobenzoic acid,
2-{ [(3,4-dichloro ■5 -isothiazolyl)carbonyl] amino } ■ ■4-chlorobenzoic acid,
2-{ [(3,4-dichloro ■5 -isotmazolyl)carbonyl] amino } ■ ■4-bromobenzoic acid,
2-{ [(3,4-dichloro ■5 -isothiazolyl)carbonyl] amino } •4-nitrobenzoic acid,
2-{ [(3,4-dichloro ■5 -isothiazolyl)carbonyl] amino } ■ ■6-methylbenzoic acid,
2-{ [(3,4-dichloro ■5-isothiazolyl)carbonyl]amino} ■ ■6-fluorobenzoic acid,
2-{ [(3,4-dichloro ■5-iso iazolyl)carbonyl]amino} ■ ■6-chlorobenzoic acid,
2-{ [(3,4-dichloro •5 -isothiazolyl)carbonyl] amino } • ■6-bromobenzoic acid,
2-{ [(3,4-dichloro ■5-isothiazolyl)carbonyl]amino}- ■5-iodobenzoic acid,
2-{ [(3,4-dichloro ■5-isothiazolyl)carbonyl]amino}- 5-methoxybenzoic acid,
2-{ [(3,4-dichloro ■5-isomiazolyl)carbonyl]amino} ■ •3,5-dichlorobenzoic acid and so on.
The isothiazolyl-carboxamides of the formula (JJ) are novel. They can be prepared by
b) reacting 3,4-dichloro-isothiazole-5-carboxylic acid chloride of the formula
Figure imgf000010_0001
with benzoic acid derivatives of the formula
Figure imgf000010_0002
wherein
R and n have the above-mentioned meanings,
in the presence of a diluent and in the presence of an acid binding agent.
The 3,4-dichlorό-isothiazole-5-carboxylic acid chloride of the formula (III) is a known compound (cf. JP-A 59024-1993).
Formula (IV) provides a general definition of the benzoic acid derivatives, which are required as reaction components for carrying out process (b) according to the invention. In this formula, R and n preferably have those meanings, which have already been mentioned in connection with the description of the substances of the formula (I) according to the invention as being preferred for this radical and this index.
The benzoic acid derivatives of the formula (IV) are known or can be prepared by known processes.
Suitable diluents for carrying out process (b) according to the invention are all customary inert organic solvents as well as water. Preference is given to using water.
Suitable acid binding agents for carrying out process (b) according to the invention are all bases, which are customary for such reactions. Preference is given to using hydroxides of alkali metals, such as hthium hydroxide, sodium hydroxide and potassium hydroxide.
When carrying out process (b) according to the invention, the reaction temperatures can be varied within a certain range. The reaction is generally carried out at a temperature between about 0°C and about 80°C, preferably between about 10°C and about 60°C. When carrying out process (b) according to the invention, 3,4-dichloro-isothiazole-5- carboxylic acid chloride of the formula (UI) and benzoic acid derivative of the formula (TV) are generally employed in equimolar amounts. However, it is also possible to use an excess of one or the other component. Working up is carried out by customary methods.
The isothiazolyl-carboxamides of the formula (IT) are also suitable for the control of undesired microorganisms, in particular for controlling fungi.
When carrying out process (a) according to the invention, all customary dehydrating agents can be used for splitting off water in the course of the reaction. Examples of such dehydrating agents are acetic anhydride, benzoic anhydride and propionic anhydride.
Suitable diluents for carrying out the process (a) according to the invention are all customary inert organic solvents. Preference is given to using aliphatic, alicyclic and aromatic hydrocarbons (that may optionally be chlorinated), for example, pentane, hexane, cyclohexane, petroleum ether, ligroine, benzene, toluene, xylene, dichloro- methane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, di- chlorobenzene, etc.; ethers, for example, ethyl ether, methyl ethyl ether, isopropyl ether, butyl ether, dioxane, dimethoxyethane (DME), tetrahydrofuran (THF), diethylene glycol dimethyl ether (DGM), etc.; ketones, for example, acetone, methyl ethyl ketone (MEK), methyl isopropyl ketone, methyl isobutyl ketone (MIBK), etc.; nitriles, for example, acetonitrile, propionitrile, acrylonitrile, etc.; esters, for example, ethyl acetate, amyl acetate, etc.; acid amides, for example, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone, l,3-dimethyl-2- imidazolidinone, hexamethylphosphoric triamide (HMPA), etc.; acid anhydrides, for example, acetic anhydride, benzoic anhydride, etc.; sulfones, sulfoxides, for example, dimethyl sulfoxide (DMSO), sulfolane, etc. and bases, for example, pyridine etc. When carrying out the process (a) according to the invention, the reaction temperatures can be varied within a substantially wide range. The reaction is generally carried out at temperatures between about -10°C and about 250°C, preferably between about 20°C and about 180°C.
The process (a) according to the invention is generally carried out under atmospheric pressure but, if desired, can also be carried out under elevated or reduced pressure.
When carrying out the process (a) according to the invention, in general an isothiazolyl-carboxamide of the formula (If) is reacted in the presence of a large excess of a dehydrating agent. If acetic anhydride is used as dehydrating agent it may simultaneously serve as a diluent. Working-up is carried out by customary methods.
The compounds according to the present invention exhibit a strong microbicidal activity. Thus, they can be used for combating undesired microorganisms, such as phytopathogenic fungi and bacteriae, in agriculture and horticulture. The compounds are suitable for the direct control of undesired microorganisms as well as for generating resistance in plants against attack by undesired plant pathogens.
Resistance-inducing substances in the present context are to be understood as those substances which are capable of stimulating the defence system of plants such that the treated plants, when subsequently inoculated with undesirable microorganisms, display substantial resistance to these microorganisms.
Undesirable microorganisms in the present case are to be understood as phytopathogenic fungi and bacteriae. The substances according to the invention can thus be employed to generate resistance in plants against attack by the harmful organisms mentioned within a certain period of time after the treatment. The period of time within which resistance is brought about in general extends from 1 to 10 days, prefer- ably 1 to 7 days, after treatment of the plants with the active compounds. Generally, the compounds according to the invention can be used as fungicides for combating phytopathogenic fungi, such as Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deutero- mycetes, and can also be used as bactericides for combating bacteriae, such as
Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae, Stre- ptomycetaceae, Proteobacteriae and Gram-positive groups.
Some pathogens causing fungal diseases which come under the generic names Hsted above are mentioned as examples, but not by way of limitation:
Erwinia species, such as, for example, Erwinia amylovora;
Pythium species, such as, for example, Pythium ultimum;
Phytophthora species, such as, for example, Phytophthora infestans; Pseudoperonospora species, such as, for example, Pseudoperonospora humuli or
Pseudoperonospora cubensis;
Plasmopara species, such as, for example, Plasmopara viticola;
Bremia species, such as, for example, Bremia Lactucae;
Peronospora species, such as, for example, Peronospora pisi or P. brassicae; Erysiphe species, such as, for example, Erysiphe graminis;
Sphaerotheca species, such as, for example, Sphaerotheca fuliginea;
Podosphaera species, such as, for example, Podosphaera leucotricha;
Venturia species, such as, for example, Venturi inaequalis;
Pyrenophora species, such as, for example, Pyrenophora teres or P. graminea (conidia form: Drechslera, syn: Helminthosporium);
Cochliobolus species, such as, for example, Cochliobolus sativus
(conidia form: Drechslera,syn: Helminthosporium);
Uromyces species, such as, for example, Uromyces appendiculatus;
Puccinia species, such as, for example, Puccinia recondita; Sclerotinia species, such as, for example, Sclerotinia sclerotiorum;
Tilletia species, such as, for example, Tilletia caries; Ustilago species, such as, for example, Ustilago nuda or Ustilago avenae; Pellicularia species, such as, for example, Pellicularia sasakii; Pyricularia species, such as, for example, Pyricularia oryzae; Fusarium species, such as, for example, Fusarium culmbrum; Botrytis species, such as, for example, Botrytis cinerea;
Septoria species, such as, for example, Leptosphaeria nodorum; Cercospora species, such as, for example, Cercospora canescens; Alternaria species, such as, for example, Alternaria brassicae; and Pseudocercosporella species, such as, for example, Pseudocercosporella herpo- trichoides.
The compounds according to the present invention are particularly suitable for causing resistance against infection of plants by plant pathogens, such as Pyricularia oryzae etc.
The good toleration, by plants, of the active compounds, at the concentrations required for combating plants diseases, permits treatment of above-ground parts of plants, of vegetative propagation stock and seeds, and of the soil.
The compounds according to the present invention have a low toxicity against warmblooded animals and therefore can be used safely.
The active compounds can be converted into the customary formulations, such as solutions, emulsions, wettable powders, suspensions, powders, foams, pastes, granu- les, tablets, aerosols, natural and synthetic materials impregnated with active compound, very fine capsules in polymeric substances, coating compositions for use on seed, and formulations used . with burning equipment, such as fumigating cartridges, fumigating cans and fumigating coils, as well as ULV cold mist and warm mist formulations. These formulations may be produced in known manner, for example by mixing the active compounds with extenders, that is to say liquid or liquefied gaseous or solid diluents or carriers, optionally with the use of surface-active agents, that is to say emulsifying agents and/or dispersing agents and or foam-forming agents. In the case of the use of water as an extender, organic solvents can, for example, also be used as auxiliary solvents.
As liquid solvents diluents or carriers, there are suitable in the main, aromatic hydrocarbons such as xylene, toluene or alkyl naphthalenes, chlorinated aromatic or chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example mineral oil fractions, alcohols, such as butanol or glycol as well as their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl-isobutyl ketone or cyclohexanone, or strongly polar solvents, such as dimethylformamide and dimethyl-sulphoxide, as well as water.
By liquefied gaseous diluents or carriers are meant liquids which would be gaseous at normal temperature and under normal pressure, for example aerosol propellants, such as halogenated hydrocarbons as well as butane, propane, nitrogen and carbon dioxide.
As solid carriers there may be used ground natural minerals, such as kaolings, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth,. and ground synthetic minerals, such as highly-dispersed silicic acid, alumina and silicates. As solid carriers for granules there may be used crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite, as well as synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks.
As emulsifying and/or foam- forming agents there may be used non-ionic and anionic emulsifiers, such as polyoxyethylene-fatty acid esters, polyoxyethylene-fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkyl sulphonates, alkyl sulphates, aryl sulphonates as well as albumin hydrolysis products.
Dispersing agents include, for example, lignin sulphite waste liquors and methyl- cellulose.
Adhesives such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and poly- vinyl acetate, can be used in the formulation.
It is possible to use colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs or metal phthalocyanine dyestuffs, and trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
The formulations in general contain from 0.1 to 95 per cent by weight of active compound, preferably from 0.5 to 90 per cent by weight.
The active compounds according to the invention can be present in the formulations or in the various use forms as a mixture with other known active compounds, such as fungicides, bactericides, insecticides, acaricides, nematicides, herbicides, bird repellents, growth factors, plant nutrients and agents for improving soil structure.
In many cases, synergistic effects are achieved, i.e. the activity of the mixture exceeds the activity of the individual components.
Examples of co-components in mixtures are the following compounds: Fungicides:
aldimorph, ampropylfos, ampropylfos potassium, andoprim, anilazine, azaconazole, azoxystrobin, benalaxyl, benodanil, benomyl, benzamacril, benzamacril-isobutyl, bialaphos, binapacryl, biphenyl, bitertanol, blasticidin-S, bromuconazole, bupirimate, buthiobate, calcium polysulphide, capsimycin, captafol, captan, carbendazim, carboxin, carvon, quinomethionate, chlobenthiazone, chlorfenazole, chloroneb, chloropicrin, chloro- thalonil, chlozolinate, clozylacon, cufraneb, cymoxanil, cyproconazole, cyprodinil, cyprofuram, carpropamide, debacarb, dichlorophen, diclobutrazole, diclofluaήid, diclomezine, dicloran, diethofencarb, difenoconazole, dimetMrimol, dimethomorph, diniconazole, diniconazole-M, dinocap, diphenylamine, dipyrithione, ditahmfos, dithianon, dodemorph, dodine, drazoxolon, edifenphos, epoxiconazole, etaconazole, etliirimol, etridiazole, famoxadon, fenapanil, fenarimol, fenbuconazole, fenfurarn, fenitropan, fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, ferbam, ferimzone, fluazinam, flumetover, fluoromide, fluquinconazole, flurprimidol, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetyl-aluminium, fosetyl-sodium, fthalide, fuberidazole, furalaxyl, furametpyr, furcarbonil, furconazole, furconazole- cis, furmecyclox, fenhexamide, fluoxastrobin, guazatine, hexachlorobenzene, hexaconazole, hymexazole, imazalil, imibenconazole, iminoctadine, iminoctadine albesilate, iminoctadine triacetate, iodocarb,' ipconazole, iprobenfos (IBP), iprodione, irumarnycin, isopro- thiolane, isovaledione, iprovalicarb, kasugamycin, kresoxim-methyl, copper preparations, such as: copper hydroxide, copper naphthenate, copper oxychloride, copper sulphate, copper oxide, oxine-copper and Bordeaux mixture, mancopper, mancozeb, maneb, meferimzone, mepampyrim, mepronil, metalaxyl, metconazole, methasulfocarb, methfuroxam, metiram, metomeclam, metsulfovax, mildiomycin, myclobutanil, myclozolin, nickel dimethyldithiocarbamate, nitrothal-isopropyl, nuarimol, ofurace, oxadixyl, oxamocarb, oxolinic acid, oxycarboxim, oxyfenthiin, paclobutrazole, pefurazoate, penconazole, pencycuron, phosdiphen, pimaricin, piperalin, polyoxin, polyoxorim, probenazole, prochloraz, procymidone, propamo- carb, propanosine-sodium, propiconazole, propineb, pyrazophos, pyrifenox, pyrimethanil, pyroquilon, pyroxyfur, prothiocpnazole, quinconazole, quintozene (PCNB), quinoxyfen, sulphur and sulphur preparations, spiroxamine, tebuconazole, tecloftalam, tecnazene, tetcyclacis, tetraconazole, thiabendazole, thicyofen, thifluzamide, thiophanate-methyl, thiram, tioxymid, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triazbutil, triazoxide, trichlamide, tricyclazole, tridemorph, triflumizole, triforine, triticonazole, trifloxystrobin, uniconazole, validamycin A, vinclozolin, viniconazole, zarilamide, zineb, ziram and also Dagger G, OK-8705,
OK-8801, α-( 1 , 1 -dimethylethyl)-β-(2-phenoxyethyl)- 1H- 1 ,2,4-triazole- 1 -ethanol, α-(2,4-dichlorophenyl)-β-fluoro-β-propyl-lH-l,2,4-triazole-l-ethanol, -(2,4-dichlorophenyl)-β-methoxy-α-methyl-lH-l,2,4-triazole-l-ethanol, α-(5-methyl- 1 ,3-dioxan-5-yl)-β-[[4-(trifiuoromethyl)-phenyl]-methylene]-lH-l ,2,4- triazole- 1 -ethanol,
(5RS,6RS)-6-hydroxy-2,2,7,7-te1xamethyl-5-(lH-l,2,4-triazol-l-yl)-3-octanone, (E)-α-(methoxyimino)-N-methyl-2-phenoxy-phenylacetamide, l-(2,4-dichlorophenyl)-2-(lH-l,2,4-triazol-l-yl)-efhanone O-(phenylmethyl)-oxime, l-(2 -methyl- 1 -naphthalenyl)- lH-pyrrol-2,5-dione,
1 -(3 , 5 -dichloropheny l)-3 -(2-propenyl)-2 , 5 -p rrolidinedione, 1 -[(diiodomethyl)-sulphonyl]-4-methyl-benzene,
1 -[[2-(2,4-dichlorophenyl)- 1 ,3-dioxolan-2-yl]-methyl]- lH-imidazole, l-[[2-(4-chlorophenyl)-3-phenyloxiranyl]-methyl]-lH-l,2,4-triazole,
1 -[ 1 -[2-[(2,4-dichlorophenyl)-methoxy]-phenyl]-ethenyl]- lH-imidazole, 1 -methyl-5-nonyl-2-(phenylmethyl)-3-pyrrohdinole,
2 6'-dibromo-2-methyl-4'-trifluoromethoxy-4-trifluoro-methyl-l,3-thiazole-5- carboxanihde,
2,6-dichloro-5-(methyl1nio)-4-pyrirrιidinyl thiocyanate,
2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide, 2,6-dichloro-N-[[4-(trifluoromethyl)-phenyl]-methyl]-benzamide,
2-(2,3,3-triiodo-2-propenyl)-2H-tetrazole,
2-[(l-memylethyl)-sulphonyl]-5-(trichloromethyl)-l,3,4-thiadiazole,
2-[[6-deoxy-4-O-(4-O-methyl-β-D-glycopyranosyl)-α-D-glucopyranosyl]-amino]-4- methoxy-lH-pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 2-aminobutane,
2-bromo-2-(bromomethyl)-pentanedinitrile,
2-chloro-N-(2,3-dmyciro-l,l,3-trimemyl-lH-inden-4-yl)-3-pyridmecarboxamide,
2-chloro-N-(2,6-dimethylphenyl)-N-(isothiocyanatomethyl)-acetamide,
2-phenylphenol (OPP), 3,4-dichloro-l-[4-(difluoromethoxy)-phenyl]-lH-pyrrol-2,5-dione,
3 ,5 -dichloro-N- [cy ano [( 1 -methyl-2-propinyl)-oxy] -methyl] -benzamide,
3 -( 1 , 1 -dimethylpropyl- 1 -oxo- 1 H-indene-2-carbonitrile,
3-[2-(4-chlorophenyl)-5-ethoxy-3-isoxazolidinyl]-pyridine,
4-chloro-2-cyano-N,N-dimethyl-5-(4-methylphenyl)-lH-imidazole-l-sulphonamide, 4-methyl-tetrazolo[l ,5-a]quinazolin-5(4H)-one,
8-hyάroxyquinoline sulphate,
9H-xanthene-2-[(phenylamino)-carbonyl3-9-carboxylic hydrazide, bis-(l -methylethyl)-3-methyl-4-[(3-methylbenzoyl)-oxy] 2,5-thiophenedicarboxylate, cis-l-(4-chlorophenyl)-2-(lH-l,2,4-triazol-l-yl)-cycloheptanol, cis-4-[3-[4-(l,l-dimethylpropyl)-phenyl-2-methylpropyl]-2,6-dimethyl- morpholinehydrochloride, ethyl [(4-chlorophenyl)-azo]-cyanoacetate, potassium hydrogen carbonate, methanetetrafhiol sodium salt, methyl l-(2,3-dihydro-2,2-dime yl-lH-mden-l-yl)-lH-imidazole-5-carboxylate, methyl N-(2,6-dimethylphenyl)-N-(5-isoxazolylcarbonyl)-DL-alaninate, methyl N-(chloroacetyl)-N-(2,6-dimethylphenyl)-DL-alaninate,
N-(2,6-dimemylphenyl)-2-methoxy-N-(tetrahydro-2-oxo-3-furanyl)-acetamide,
N-(2,6-dime ylphenyl)-2-memoxy-N-(tetrahydro-2-oxo-3-tMenyl)-acetamide,
N-(2-chloro-4-nitrophenyl)-4-methyl-3-nitro-benzenesulphonamide, N-(4-cyclohexylphenyl)- 1 ,4,5,6-tetrahydro-2-pyrimidineamine,
N-(4-hexylphenyl)- 1 ,4,5,6-tetrahydro-2-ρyrimidineamine,
N-(5-chloro-2-methylphenyl)-2-methoxy-N-(2-oxo-3-oxazolidinyl)-acetamide,
N-(6-methoxy)-3-pyridinyl)-cyclopropanecarboxamide,
N-[2,2,2-1richloro-l-[(cMoroace1yl)-ammo]-emyl]-berzamide, N- [3 -chloro-4, 5 -bis(2-propinyloxy)-pheny 1] -N' -methoxy-memanimidamide,
N-formyl-N-hydroxy-DL-alanine-sodium salt,
O,O-diethyl [2-(dipropylarmno)-2-oxoethyl]-ethylphosphoramidothioate, O-methyl S-phenyl phenylpropylphosphoramidothioate,
S-methyl 1 ,2,3 -benzothiadiazole-7-carbothioate, spiro[2H]-l-benzopyran-2, (3Η)-isobenzofuran]-3'-one,
Bactericides:
bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations. Insecticides / acaricides / nematicides:
abamectin, acephate, acetamiprid, acrinathrin, alanycarb, aldicarb, aldoxycarb, alpha- cypermethrin, alphamethrin, amitraz, avermectin, AZ 60541, azadirachtin, azamethiphos, azinphos A, azinphos M, azocyclotin,
Bacillus popilhae, Bacillus sphaericus, Bacillus subtilis, Bacillus thuringiensis, baculoviruses, Beauveria bassiana, Beauveria tenella, bendiocarb, benfuracarb, bensultap, benzoximate, betacyfluthrin, bifenazate, bifenthrin, bioe anomethrin, biopermethrin, BPMC, bromophos A, bufencarb, buprofezin, butathiofos, butocarboxim, butylpyridaben, cadusafos, carbaryl, carbofuran, carbophenothion, carbosulfan, cartap, chloethocarb, chlorethoxyfos, chlorfenapyr, chlorfenvinphos, chlorfluazuron, chlormephos, chlorpyrifos, chlorpyrifos M, cMovaporthrin, cis-resmethrin, cispermethrin, clocythrin, cloethocarb, clofentezine, cyanophos, cycloprene, cycloprothrin, cyfluthrin, cyhalothrin, cyhexatin, cypermethrin, cyromazine, deltamethrin, demeton M, demeton S, demeton-S-methyl, diafenthiuron, diazinon, dichlorvos, diflubenzuron, dimethoat, dimethylvinphos, diofenolan, disulfoton, docusat-sodium, dofenapyn, eflusilanate, emamectin, empenthrin, endosulfan, Entomopfthora spp., esfenvalerate, ethiofencarb, ethion, ethoprophos, etofenprox, etoxazole, etrimphos, fenamiphos, fenazaquin, fenbutatin oxide, fenitrothion, fenothiocarb, fenoxacrim, fenoxycarb, fenpropathrin, fenpyrad, fenpyrithrin, fenpyroximate, fenvalerate, fipronil, fluazuron, flubrocythrinate, flucycloxuron, flucythrinate, flufenoxuron, flutenzine, fluvalinate, fonophos, fosmethilan, fosthiazate, fubfenprox, furathiocarb, granulosis viruses, halofenozide, HCH, heptenophos, hexaflumuron, hexythiazox, hydroprene, imidacloprid, isazophos, isofenphos, isoxathion, ivermectin, lambda-cyhalothrin, lufenuron, malathion, mecarbam, metaldehyde, methamidophos, Metharhizium anisopliae, Metharhizium flavoviride, methidathion, methiocarb, methomyl, methoxyfenozide, metolcarb, metoxadiazone, mevinphos, milbemectin, monocrotophos, naled, nitenpyram, nithiazine, novaluron, nuclear polyhedrosis viruses, omethoat, oxamyl, oxydemethon M,
Paecilomyces fumosoroseus, parathion A, parathion M, permethrin, phenthoat, phorat, phosalone, phosmet, phosphamidon, phoxim, pirimicarb, pirimiphos A, pirimiphos M, profenofos, promecarb, propoxur, prothiofos, prothoat, pymetrozine, pyraclofos, pyresmethrin, pyrethrum, pyridaben, pyridathion, pyrimidifen, pyriproxyfen, quinalphos, ribavirin, salithion, sebufos, silafluofen, spinosad, sulfotep, sulprofos, tau-fluvalinate, tebufenozide, tebufenpyrad, tebupirimiphos, teflubenzuron, tefluthrin, temephos, temivinphos, terbufos, tetrachlorvinphos, theta-cypermethrin, thiamethoxam, thiapronil, thiatriphos, thiocyclam hydrogen oxalate, thiodicarb, thiofanox, muringiensin, tralocythrin, tralomethrin, triarathehe, triazamate, triazophos, triazuron, trichlophenidirie, trichlorfon, triflumuron, trimethacarb, thiacloprid, vamidothion, vaniliprole, Verticillium lecanii,
YI 5302, zeta-cypermethrin, zolaprofos,
( lR-cis)- [5 -(phenylmethyl)-3 -furanyl] -methyl-3 -[(dihydro-2-oxo-3 (2H)- furanylidene)-methyl] 2,2-dimethylcyclopropanecarboxylate,
(3-phenoxyphenyl)-methyl 2,2,3,3-tetramethylcyclopropanecarboxylate,
1 -[(2-chloro-5-thiazolyl)methyl]tetrahydro-3,5-dimethyl-N-nitro- 1 ,3 ,5-triazine- 2(lH)-imine,
2-(2-chloro-6-fluorophenyl)-4-[4-( 1 , 1 -dimethylethyl)phenyl]-4,5-dihydro-oxazole,
2-(acetyloxy)-3-dodecyl-l,4-naphthalenedione,
2-chloro-N-[[[4-(l-phenylethoxy)-phenyl]-amino]-carbonyl]-benzamide,
2-chloro-N-[[[4-(2,2-dichloro- 1 , 1 -difluoroethoxy)-phenyl]-amino.]-carbonyl]- benzamide,
3-methylphenyl propylcarbamate 4-[4-(4-ethoxyphenyl)-4-methylpentyl]- 1 -fluoro-2-phenoxy-benzene,
4-c oro-2-(l,l-dimethylethyl)-5-[[2-(2,6-dimemyl-4-phenoxyphenoxy)emyl]thio]-
3 (2H)-pyridazinone,
4-cMoro-2-(2-chloro-2-methylpropyl)-5-[(6-iodo-3-pyridinyl)methoxy]-3(2H)-pyri- dazinone,
4-chloro-5-[(6-chloro-3-pyridinyl)methoxy]-2-(3,4-dichlorophenyl)-3(2H)-pyri- dazinone,
Bacillus thuringiensis strain EG-2348,
[2-benzoyl- 1 -( 1 , 1 -dimethyiethyl)-hydrazinobenzoic acid, 2,2-dimethyl-3-(2,4-dichlorophenyl)-2-oxo-l-oxaspiro[4.5]dec-3-en-4-yl butanoate,
[3 - [(6-chloro-3 -pyridinyl)methyl] -2-thiazolidinylidene] -cy anamide, dihydro-2-(nitromethylene)-2H-l,3-thiazine-3(4H)-carboxaldehyde, ethyl [2-[[l,6-dihydro-6-oxo-l-(phenylmethyl)-4-pyridazinyl]oxy]ethyl]-carbamate,
N-(3 ,4,4-trifluoro- 1 -oxo-3-butenyl)-glycine, N-(4-chlorophenyl)-3-[4-(difluoromethoxy)phenyl]-4,5-dihydro-4-phenyl-lH-pyra- . zole- 1 -carboxamide,
N- [(2-chloro-5 -thiazolyl)methyl] -Nc -methyl-N"-nitro-guanidine,
N-methyl-N'-( 1 -methyl-2-propenyl)- 1 ,2-hydrazinedicarbothioamide,
N-methyl-N'-2-propenyl- 1 ,2-hydrazinedicarbothioamide, O,O-diethyl [2-(dipropylammo)-2-oxoethyl]-ethylphosphoramidothioate.
The active compounds can be used as such or in the form of their formulations or the use forms prepared therefrom by further dilution, such as ready-to-use solutions, emulsions, suspensions, powders, tablets, pastes, microcapsules and granules. They are used in the customary manner, for example by watering, immersion, spraying, atomising, misting, vaporizing, injecting, forming a slurry, brushing on, dusting, scattering, dry dressing, moist dressing, wet dressing, slurry dressing or encrusting.
In the treatment of parts of plants, the active compounds concentration in the use forms can be varied within a substantial range. They are, in general, from 1 to
0.0001% by weight, preferably from 0.5 and 0.001%. For the treatment of seed, amounts of active compound of 0.1 to 10 g, especially 1 to 5 g, are generally employed per kilogram of seed.
For the treatment of soil, active compound concentrations, at the point of action, of
0.00001 to 0.1% by weight, especially of 0.0001 to 0.02%, are generally employed.
As already mentioned above, all plants and parts of plants can be treated according to the invention. In a preferred embodiment naturally occurring plant species and plant varieties or those obtained by conventional biological breeding methods, such as crossbreeding or protoplast fusion as well as parts of such plants are treated. In an additional preferred embodiment transgenic plants and plant varieties which have been obtained by genetic engineering methods, possibly in combination with conventional methods (genetically modified organisms) and parts of such plants are treated. The term "parts" or "parts of plants" or "plant parts" is explained above.
According to the invention plants of the plant varieties commercially available or used at any particular time are very preferably treated. Plant varieties are understood to be plants with specific properties ("traits") which have been obtained both by conventional breeding, by mutagenesis or by recombinant DNA techniques. They can be varieties, biotypes or genotypes.
Depending on the species or varieties of plants, their location and growth conditions (the types of soil, climate, vegetation period and feed concerned), superadditive ("synergistic") effects can occur as a result of the treatment according to the invention. Effects such as for example reduced application rates and/or broadening of the activity spectra and/or increased activity of the compounds and compositions usable according to the invention, improved plant growth, increased tolerance of high or low temperatures, increased tolerance of dry conditions or water or ground salt contents, increased flowering capacity, facilitated harvesting, acceleration of maturity, increased crop yields, higher quality and/or increased nutritional value of the harvested crops and increased storing quality and/or processibility of the harvested crops are possible, which are greater than those actually expected.
Preferred transgenic plants or plant varieties (obtained by genetic engineering) to be treated according to the invention include all plants which as a result of the genetic modification concerned have received genetic material which provides them with particularly advantageous valuable properties ("traits"). Examples of such properties are improved plant growth, increased tolerance of high or low temperatures, increased tolerance of dry conditions or water or ground salt contents, increased flowering capacity, facilitated harvesting, acceleration of maturity, increased crop yields, higher quality and/or increased nutritional value of the harvested crops and increased storing quality and/or processibility of the harvested crops. Additional and particularly noteworthy examples of such properties are increased resistance of the plants to animal and microbial pests, such as to insects, mites, phytopathogenic fungi, bacteria and/or viruses as well as increased tolerance by the plants of certain herbicidal active compounds. Examples which may be mentioned of transgenic plants are the important crop plants such as cereals (wheat and rice), corn, soybeans, potatoes, cotton, rape and fruit plants (producing apples, pears, citrus fruits and grapes), the crop plants com, soybeans, potatoes, cotton and rape being particularly noteworthy. Particularly significant properties ("traits") are increased resistance of the plants to insects due to the toxins forming in the plants, and in particular those which are produced in the plants (hereinafter referred to as "Bt plants") by the genetic material obtained from Bacillus Thuringiensis (e.g. by the genes CrylA(a), CrylA(b), CrylA(c), CryllA, CryirfB2, Cry9c Cry2Ab, Cry3Bb and CrylF and combinations thereof). Particularly significant properties ("traits") are the increased resistance of plants to fungi, bacteria and viruses due to systemically acquired resistance (SAR), systemin, phytoalexins, elicitors and resistance genes and correspondingly expressed proteins and toxins. Particularly significant properties ("traits") are also increased tolerance by the plants of certain herbicidal active compounds, such as for example imidazolinones, sulphonylureas, glyphosate or phosphinotricine (e.g. the "PAT" gene). The corresponding genes imparting the required properties ("traits") can also occur in the transgenic plants in combination with each other. Examples which may be mentioned of "Bt plants" are varieties of corn, cotton, soybeans and potatoes which are sold under the trade names YIELD GARD® (e.g. corn, cotton, soybeans), KnockOut® (e.g. corn), StarLink® (e.g. com), Bollgard® (cotton), Nucotn® (cotton) and NewLeaf® (potatoes). Examples which may be mentioned of herbicide-tolerant plants are varieties of corn, cotton and soybeans which are sold under the trade names Roundup Ready® (tolerance of glyphosate, e.g. corn, cotton, soybeans), Liberty Link® (tolerance of phosphinotricine, e.g. rape), J I® (tolerance of imidazolinones) and STS® (tolerance of sulphonylureas, e.g. com). Herbicide- resistant plants (bred for herbicide tolerance in the conventional manner) which may be mentioned are also the varieties (e.g. com) sold under the name Clearfield®. The above statements do of course also apply to any plant varieties which may be developed in the future or launched onto the market in the future and which have the genetic properties ("traits") described above or developed in the future.
According to the invention the above-mentioned plants can be particularly advantageously treated with the compounds of the general formula I or the active compound mixtures according to the invention. The preferred ranges mentioned above for the active compounds or mixtures also apply to the treatment of these plants. Particularly advantageous is the treatment of plants with the compounds or mixtures specifically listed in the present text.
The preparation and the use of the compounds according to the invention is illustrated by the following examples. The invention, however, is not limited to said examples in any way. Synthesis Example 1
(Compound No. I -7)
Figure imgf000028_0001
15 ml of acetic anhydride were added to 1.0 g 2-(3,4-dichloro-isothiazol-5-yϊ- carbonylamino)-5-bromo-benzoic acid, and the resulting mixture was refluxed for 2 hours. Subsequently, the reaction mixture was cooled down to room temperature and was then further cooled by means of ice water. The precipitating crystals were filtered off and washed with methanol to obtain 2-(3,4-dichloro-isothiazol-5-yl)-6- bromo-4H-4-oxo-3,l-benzoxazine (0.6 g). m p l69-173°C.
The compounds shown in the following Table 1 were also prepared according to the method described in Synthesis Example 1.
Table 1
Figure imgf000029_0001
Compound No. (R)n mp (°C) ornD
1-1 - 191-192
1-2 8-CH3 211-222
1-3 8-C1 . 208-209 .
1-4 7-C1 203-206
1-5 . 6-C1 191-194
1-6 5-C1 204-206
1-7 6-Br 169-173
1-8 6^CH3 189-190
1-9 . 5-CH3 176-177
1-10 5-F 200-202
1-11 6-OCH3 186-187
1-12 6,7-CH=CH-CH=CH- 245-246
1-13 6,8-Cl2 180-182 •
1-14 7-NO2 216-218
1-15 7-CH3 220-221 '
1-16 6-1 160-166
1-17 6,7-F2 131-133
1-18 6,7,8-(OCH3)3 199-201
1-19 6,8-Br2 207-210
1-20 8-OCH3 226-228
1-21 8-CF3 188-191 Table 1 (continued)
Compound No. (R)n mp (°C) ornD 20
1-22 7-F
1-23 6-F
1-24' 6,8-(CH3)2
1-25 6-NO2
1-26 6,7-(OCH3)2
1-27 7,8-Cl2
1-28 5,8-Cl2
1-29 5,6,7,8-F4
1-30 6-CH3,8-Br
1-31 7-COOH
1-32 6,8-I2
1-33 5-F, 6,8-Br2
1-34 5-COOH
1-35 6-NHCOCH3
1-36 6,7-Br2
.1-37 8-NO2
1-38 5,6,7,8-Cl4
1-39 5-C1, 6,8-Br2
1-40 5-CF3
1-41 5-OCH3
1-42 6-SO2N(CH3)2 .
1-43 6-OCF3
1-44 6,7-(CH2)4-
1-45 6,8-(CH3)2
1-46 7-NHCO2C2H5 Table 1 (continued)
Compound No. (R)Ω p (°C) or nD 20
Figure imgf000031_0001
1-49 . 5,8-(CH3)2
1-50 7-CF3
1-51 8-CF3
1-52 5,6-CH=CH-CH=CH
1-53 6-SCH3
1-54 6,7-OCF2O-
1-55 6,8-F2
1-56 7-SO2CH3
1-57 7-OCH3
Synthesis Example 2 (Intermediate)
(Compound No. II - 7)
Figure imgf000032_0001
2.0 g of 3,4-dichloro-isothiazole-5-carboxylic acid chloride were added dropwise to a solution of 0.62 g of sodium hydroxide and 2.0 g of 2-amino-5-bromo-benzoic acid in 20 ml of water whilst stirring at room temperature. After stirring the reaction mixture for one more hour at room temperature, the precipitating crystals were filtered off and washed with water and then with hexane to obtain 2.37 g of 2-(3,4- dichloro-isomiazol-5-yl-carbonylamino)-5-bromo-benzoic acid, m p >250°C
The compounds shown in the following Table 2 were also prepared according to the method described in Synthesis Example 2.
Table 2
Figure imgf000033_0001
Compound No. (R)n mp (°C) or nD υ
π-i . >250 π-2 3-CH3 209-213 π-3 3-C1 195-198 π-4 4-C1 >250 π-5 5-C1 238-246 π-6 6-C1 196-201 π-7 5-Br >250 π-8 5-CH3 229-237 π-9 6-CH3 200-205 π-io 6-F . 195-198 π-i i 5-OCH3 220-229 π-12 4,5-CH=CH-CH=CH- >250 π-i4 4-NO2 245-248 ' π-13 3,5-Cl2 π-i5 4-CH3 234-236 π-i6 5-1 232-240 π-17 4,5-F2 207-210
II- 18 3,4,5-(OCH3)3 166-169 Table 2 (continued)
Compound No. (R)n mp (°C) or nD 20
π-19 3,5-Br2 π-20 3-OCH3 183-189 π-21 3-CF3 π-22 4-F >250 π-23 5-F >250 ' π-24 3,5-(CH3)2 π-25 5-NO2 π-26 4,5-(OCH3)2 >250 π-27 3,4-Cl2; π-28 3,6-Cl2 π-29 3,4,5,6-F4 π-30 3- Br, 5-CH3 π-3i 4-COOH ' >250 π-32 3,5-Ii π-33 3,5-Br2> 6-F, π-34 6-COOH π-35 5-NHCOCH3 π-36 4,5-Br2 π-37 3-NO2 π-38 3,4,5,6-Cl4 π-39 6-Cl, 3,5-Br2 π-40 6-CF3 π-41 6-OCH3 π-42 5-SO2N(CH3)2 π-43 5-OCF3 π-44 4,5-(CH2)4- Table 2 (continued)
Compound No. (R)n mp (°C) or nD : 20
11-45 3,5-(CH3)2 π-46 4-NHCO2C2H5
Figure imgf000035_0001
π-49 3,6-(CH3)2 π-50 4-CF3 ' π-5i 3-CF3
Figure imgf000035_0002
π-56 4-SO2CH3
Figure imgf000035_0003
Biological Test Examples
Test Example A
Test of foliar spray effect against Pyricularia oryzae
Preparation of formulations of the compounds tested
Active compound: 30 - 40 parts by weight Carrier: mixture of diatomaceous earth and kaolin (1 :5), 55-65 parts by weight
Emulsifier: polyoxyethylene alkyl phenyl ether, 5 parts by weight
The above-mentioned amounts of active compound, carrier and emulsifier were crushed and mixed to make a wettable powder. A portion of the wettable powder comprising the prescribed amount of active compound was diluted with water and used for testing.
Testing procedure
Seedlings of paddy rice (variety: Kusabue) were cultured in plastic pots each having a diameter of 6 cm. The previously prepared solution of the prescribed concentration of active compound was sprayed over the seedlings in the 1.5 - 2 leaf stage, at a rate of 20 ml per 3 pots. 5 days after the application, a suspension of spores of artificially cultured Pyricularia oryzae was sprayed on the test plants once for inoculation, and the plants were kept at 25°C and 100% relative humidity for infection. 7 days after the inoculation, the infection rate per pot was classified and evaluated according to the following standard and the control value (%) was calculated. Phytotoxicity was tested at the same time. This test is an average of the results of 3 pots for 1 section. The evaluation of the infection rate and the calculation method of the control value are identical in each of the Test Examples A and B. Infection rate Percentage of lesion area in (%)
0 0
0.5 less than 2
1 2-less than 5
2 5 -less than 10
3 10-less than 20
4 20-less than 40
5 more than 40
Infection rate of treated section
Control value (%) = x 100 Infection rate of untreated section
Test results
Compounds No. 1-4, 1-5, 1-6, 1-7, 1-8,1-9, 1-10, 1-11, 1-13, 1-14, 1-15, 1-17, II-l, II-4, π-5, π-6, π-7, π-8, π-9, π-io, π-n, π-12, π-14, π-15, π-iβ, π-17, π-is, π-20, π-22, 11-23, π-26 and H-32 showed control values of more than 80% at an active compound concentration of 500 ppm. No phytotoxicity was observed.
Test Example B
Test for the effect of seed treatment against Pyricularia oryzae.
Testing procedure
Seeds of paddy rice (variety: Kasabue) were drenched in a previously prepared diluted solution of an active compound having the prescribed concentration. 5 ml of such solution were used per 150 grains of seed. Drenching was conducted at a temperature of 20°C for 5 days. After the drenching, the air-dried seeds were sown in 2 plastic pots, each having a diameter of 9 cm, and the seeds were germinated by placing the pots in a warmed nursery box (32°C) for 3 days. After cultivating the seedlings for 2 weeks, the plants reached the 2 - 2.5 leaf stage. A spore suspension of artificially cultured Pyricularia oryzae was then sprayed on the test plants once, and the plants were kept at a temperature of 25°C and a relative atmospheric humidity of 100% for infection. Seven days after the inoculation, the infection rate per pot was classified and evaluated and the control value (%) was calculated. Phytotoxicity was tested at the same time.
This test is an average of the results of 3 pots per one section.
Test results
Compounds No. 1-1, 1-4, 1-5, 1-6, 1-8, 1-9, 1-11, 1-12, 1-13, 1-15, 1-16, 1-21, II-l, H-3, π-4, π-5, π-6, π-10, π-16, π-17, π-26 and π-32 showed control values of more than 80%o an active compound concentration of 500 ppm. No. phytotoxicity was observed.
Formulation Examples
Formulation Example I (Granules)
25 parts by weight of water were added to a mixture of 10 parts by weight of Compound No. 1-1 according to the invention, 30 parts by weight of bentonite (mont- morillonite), 58 parts by weight of talc and 2 parts by weight of lignin sulphonic acid salt, and the mixture was kneaded thoroughly. The resulting product was granulated by means of an extrusion granulator to form granules having a size of from 10 to 40 meshes. The granules were dried at a temperature between 40 and 50°C.
Formulation Example H (Granules)
95 parts by weight of a clay mineral having a particle size distribution within a range of from 0.2 to 2 mm were introduced into a rotary mixer. This product was uniformly wetted by spraying thereto under rotation a mixture of 5 parts by weight of Compound No. 1-4 according to the invention and a liquid diluent. The granules obtained in this manner were dried at a temperature between 40 and 50°C.
Formulation Example Ifl (Emulsifiable Concentrate)
An emulsifiable concentrate was prepared by mixing 30 parts by weight of Compound No. 1-6 according to the invention, 5 parts by weight of xylene, 8 parts by weight of polyoxyethylene alkyl phenyl ether and 7 parts by weight of calcium alkylbenzene sulphonate with stirring.
Formulation Example IV (Wettable Powder)
A wettable powder was prepared by thoroughly mixing 15 parts by weight of Com- pound No. 1-8 according to the invention, 80 parts by weight of a mixture (1:5) of
White Carbon (fine powder of hydrated non-crystalline silicon oxide) and powdery clay, 2 parts by weight of sodium alkylbenzene sulphonate and 3 parts by weight of a condensate of sodium alkylnaphthalene sulphonate and formaldehyde in powdery state.
Formulation Example V (Water Dispersible Granules)
20 parts by weight of Compound No. 1-15 according to the invention, 30 parts by weight of sodium lignin sulphonate, 15 parts by weight of bentonite and 35 parts by weight of calcined diatomaceous earth powder were thoroughly mixed with water.
The resulting product was granulated by means of extrusion through a 0.3 mm screen. After drying the product, water dispersible granules were obtained.

Claims

Patents Claims
Isothiazolyl-benzoxazine derivatives of the formula
Figure imgf000041_0001
wherein
R represents halogen, alkyl, alkoxy, alkylthio, alkylsulfonyl, haloalkyl, haloalkoxy, carboxy, N,N-dialkyl-sulfamoyl, acylamino, alkoxy- carbonylamino, phenyl, phenoxy or nitro, or two adjacent radicals may together form a group selected from alkylene, alkenylene, alkylene- dioxy or haloalkylenedioxy and
n represents 0, 1, 2, 3 or 4.
Isothiazolyl-benzoxazine derivatives of the formula (I) according to claim 1, in which
R represents fluoro, chloro, bromo, iodo, alkyl having 1 to 6 carbon atoms, alkoxy having 1 to 6 carbon atoms, alkylthio having 1 to 6 carbon atoms, alkylsulfonyl having 1 to 6 carbon atoms, haloalkyl having 1 to 6 carbon atom and 1 to 9 identical or different halogen atoms, haloalkoxy having 1 to 6 carbon atoms and 1 to 9 identical or different halogen atoms, carboxy, N,N-dialkyl-sulfamoyl having 1 to 6 carbon atoms in each of the alkyl groups, alkylcarbonylamino having 1 to 6 carbon atoms in the alkyl part, alkoxycarbonylamino having 1 to 6 carbon atoms in the alkoxy part, phenyl, phenoxy or nitro, or two adjacent radicals together form a group selected from alkylene having 3 to 6 carbon atoms alkenylene having 4 to 6 carbon atoms, alkylenedioxy having 1 or 2 carbon atoms and 2 non-adjacent oxygen atoms, or haloalkylenedioxy having 1 to 4 carbon atoms and 2 non- adjacent oxygen atoms and 1 to 5 identical or different halogen atoms, and
n is 0, 1,
2, 3 or 4.
3. Isothiazolyl-benzoxazine derivatives of the formula (I) according to claim 1, in which
R represents fluoro, chloro, bromo, iodo, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, alkylthio having 1 to 4 carbon atoms, alkylsulfonyl having 1 to 4 carbon atoms, haloalkyl having 1 to 4 carbon atoms and 1 to 5 identical or different halogen atoms, haloalkoxy having 1 to 4 carbon atoms and 1 to 5 identical or different halogen atoms, carboxy, N,N-dialkyl-sulfamoyl having 1 to 4 carbon atoms in each of the alkyl^oups, alkylcarbonylamino having
1 to 4 carbon atoms in the alkyl part, alkoxycarbonylamino having 1 to 4 carbon atoms in the alkoxy part, phenyl, phenoxy or nitro,
or two adjacent radicals together form a group selected from -(012)3-, -(CH2)4-, -CH=CH-CH=CH-, -O-CH2-O-, -O-CH2-CH2-O-,
-O-CF2-O- and -O-CF2-CF2-O-, and
n is 0, 1, 2, 3 or 4.
4. Isothiazolyl-benzoxazine derivatives of the formula (I) according to claim 1, in which R represents fluoro, chloro, bromo, iodo, methyl, ethyl, mefhoxy, ethoxy, methylthio, methylsulfonyl, trifluoromethyl, trichloromethyl, difluorome hyl, trifluoromethoxy, difiuoromethoxy, carboxy, N,N- dimethyl-sulfamoyl, methylcarbonylamino, e ylcarbonylamiήo, methoxycarbonylammo, e oxycarbonylamino, phenyl, phenoxy or nitro, or
two adjacent radicals represent a group selected from -(CH2)3-, -(CH2)4-, -CH=CH-CH=CH-, -O-CH2-O-, -O-CH2-CH2-O-,
-O-CF2-O- and -O-CF2-CF2-O-, and .
5. Isothiazolyl-benzoxazine derivatives of the formula (I) according to claim 1, in which
R represents fluoro, chloro, bromo, iodo, methyl, trifluoromethyl or nitro, or
two adjacent radicals represent the group -CH=CH-CH=CH-, and
n represents 0, 1 or 2, wherein the radicals may be identical or different, if n is 2.
6. Process for the preparation of isothiazolyl-benzoxazine derivatives of the formula (I) according to claim 1, characterized in that
a) isothiazolyl-carboxamides of the formula
Figure imgf000044_0001
wherein
R and n have the meanings mentioned in claim 1
are reacted with dehydrating agents in the presence of an inert diluent.
7. Microbicidal compositions, characterized in that they contain at least one isothiazolyl-benzoxazine derivative of the formula (I) according to claim 1 plus extenders and/or surface-active agents.
8. Process for combating undesired microorganisms, characterized in that isothiazolyl-benzoxazine derivatives of the formula (I) according to claim 1 are applied to the microorganisms and/or to their habitat.
9. Use of isothiazolyl-benzoxazine derivatives of the formula (I) according to claim 1 for combating undesired microorganisms.
10. , Process for the preparation of microbicidal compositions, characterized in that isothiazolyl-benzoxazine derivatives of the formula (I) according to claim 1 are mixed with extenders and/or surface active agents.
11. Isothiazolyl-carboxamides of the formula
Figure imgf000045_0001
wherein
R represents halogen, alkyl, alkoxy, alkylthio, alkylsulfonyl, haloalkyl, haloalkoxy, carboxy, N,N-dialkyl-sulfamoyl, acyla ino, alkoxy- carbonylamino, phenyl, phenoxy, or nitro, or two adjacent radicals may together form a group selected from alkylene, alkenylene, alkylenedioxy or haloalkylenedioxy, and
n represents 0, 1, 2, 3 or 4.
12. Process for the preparation of isothiazolyl-carboxamides of the formula (TI), characterized in that
b) 3,4-dichloro-isothiazole-5-carboxylic acid chloride of the formula
Figure imgf000045_0002
with benzoic acid derivatives of the formula
Figure imgf000046_0001
wherein
R and n have the meanings mentioned in claim 11,
in the presence of a diluent and in the presence of an acid binding agent.
PCT/EP2003/012475 2002-11-20 2003-11-08 Isothiazolyl-benzoxazine derivatives WO2004046140A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003288012A AU2003288012A1 (en) 2002-11-20 2003-11-08 Isothiazolyl-benzoxazine derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002-336329 2002-11-20
JP2002336329A JP2004168707A (en) 2002-11-20 2002-11-20 Isothiazolylbenzoxazine derivative and disease injury-controlling agent

Publications (1)

Publication Number Publication Date
WO2004046140A1 true WO2004046140A1 (en) 2004-06-03

Family

ID=32321801

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/012475 WO2004046140A1 (en) 2002-11-20 2003-11-08 Isothiazolyl-benzoxazine derivatives

Country Status (3)

Country Link
JP (1) JP2004168707A (en)
AU (1) AU2003288012A1 (en)
WO (1) WO2004046140A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007044724A3 (en) * 2005-10-06 2007-06-28 Exelixis Inc Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
CN102942565A (en) * 2012-11-06 2013-02-27 江西天人生态股份有限公司 3,4-dichloro isothiazole derivatives, their preparation method and application

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2188274A4 (en) * 2007-08-03 2011-05-25 Boehringer Ingelheim Int Viral polymerase inhibitors
EP2809322B9 (en) * 2012-01-26 2019-10-30 PTC Therapeutics, Inc. Compounds for treating spinal muscular atrophy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987257A1 (en) * 1997-05-28 2000-03-22 Nihon Nohyaku Co., Ltd. 1,2,3-thiadiazole derivatives, plant disease controlling agent, and method for use thereof
JP2001019691A (en) * 1999-07-08 2001-01-23 Nissan Chem Ind Ltd Pyrazolebenzoxazine or pyrazolebenzothiazine compound and antifungal agent for agriculture and horticulture
JP2001139566A (en) * 1999-11-16 2001-05-22 Nippon Nohyaku Co Ltd Pest control agent and method for using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987257A1 (en) * 1997-05-28 2000-03-22 Nihon Nohyaku Co., Ltd. 1,2,3-thiadiazole derivatives, plant disease controlling agent, and method for use thereof
JP2001019691A (en) * 1999-07-08 2001-01-23 Nissan Chem Ind Ltd Pyrazolebenzoxazine or pyrazolebenzothiazine compound and antifungal agent for agriculture and horticulture
JP2001139566A (en) * 1999-11-16 2001-05-22 Nippon Nohyaku Co Ltd Pest control agent and method for using the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 16 8 May 2001 (2001-05-08) *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 22 9 March 2001 (2001-03-09) *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007044724A3 (en) * 2005-10-06 2007-06-28 Exelixis Inc Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
US8053454B2 (en) 2005-10-06 2011-11-08 Exelixis, Inc. Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3
AU2006302174B2 (en) * 2005-10-06 2013-06-20 Exelixis, Inc. Pyridopyrimidinone Inhibitors of PIM-1 and/or PIM-3
CN102942565A (en) * 2012-11-06 2013-02-27 江西天人生态股份有限公司 3,4-dichloro isothiazole derivatives, their preparation method and application
CN102942565B (en) * 2012-11-06 2016-01-27 江西天人生态股份有限公司 One class 3,4-dichloro Isothizole derivatives and its production and use

Also Published As

Publication number Publication date
JP2004168707A (en) 2004-06-17
AU2003288012A1 (en) 2004-06-15

Similar Documents

Publication Publication Date Title
US6369093B1 (en) Pyrazole carboxanilide fungicide
JP2010248217A (en) Isothiazolecarboxylic acid amides
WO2000073290A1 (en) Isothiazolecarboxamides and their use as microbicides
WO2001077090A2 (en) Isothiazole derivatives and their use as microbicides
US8188129B2 (en) (−)-enantiomer of the 2-[2-(1-chloro-cyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione
US20030176477A1 (en) Isothiazolecarboxylic acid derivatives and their use as microbicides
WO2001064644A1 (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
WO2004046140A1 (en) Isothiazolyl-benzoxazine derivatives
JP2003507360A (en) Aminosalicylic acid amides and their use for controlling plant harmful organisms
WO2002051845A2 (en) Triazolopyrimidines
WO2002051822A2 (en) Isothiazolecarboxamides as microbicides
US6566383B2 (en) Sulfonyltriazol derivatives and their use for combating micro-organisms
WO2003031420A1 (en) Isothiazole derivatives
US6359142B1 (en) Sulfonyl oxazolones and their use for combating undesirable microorganisms
US20040242662A1 (en) Azinyl sulfonylimidazoles for use as microbicidal agents
WO2003042198A1 (en) Isothiazole derivatives
US20050049285A1 (en) Dichloropyridyl methyl cyanamidines
JP2003505386A (en) Thienyl-pyrazoles and their use for controlling pests
US20040077880A1 (en) Sulfonylpyrroles
WO2001029014A1 (en) Isothiazole-5-carboxylic esters as microbicides
MXPA01002294A (en) Pyrazole carboxanilides
WO2001034576A2 (en) Use of pyrimidinone derivatives for controlling undesired microorganisms
JP2002531433A (en) Substituted oximes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP